Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Acitretin or Tazarotene Gel and Excimer Laser for Treatment of Psoriasis

This study has been terminated.
(lack of efficacy and lack of funding)
Information provided by (Responsible Party):
Kristina Callis, University of Utah Identifier:
First received: March 25, 2010
Last updated: March 6, 2012
Last verified: March 2012
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: October 2011
  Primary Completion Date: September 2011 (Final data collection date for primary outcome measure)